|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US6893625B1
(en)
|
1986-10-27 |
2005-05-17 |
Royalty Pharma Finance Trust |
Chimeric antibody with specificity to human B cell surface antigen
|
|
ATE195022T1
(de)
|
1987-04-27 |
2000-08-15 |
Unilever Nv |
Spezifische bindungstestverfahren
|
|
US5120643A
(en)
|
1987-07-13 |
1992-06-09 |
Abbott Laboratories |
Process for immunochromatography with colloidal particles
|
|
AU2684488A
(en)
|
1988-06-27 |
1990-01-04 |
Carter-Wallace, Inc. |
Test device and method for colored particle immunoassay
|
|
US5252496A
(en)
|
1989-12-18 |
1993-10-12 |
Princeton Biomeditech Corporation |
Carbon black immunochemical label
|
|
FI941572L
(fi)
|
1991-10-07 |
1994-05-27 |
Oncologix Inc |
Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
|
|
US6034078A
(en)
|
1992-05-29 |
2000-03-07 |
Eli Lilly And Company Limited |
Thienobenzodiazepine compounds
|
|
DK0582368T3
(da)
|
1992-05-29 |
2001-02-05 |
Lilly Co Eli |
Thienobenzodiazepinderivater til behandling af forstyrrelser i centralnervesystemet
|
|
US5642870A
(en)
|
1992-08-05 |
1997-07-01 |
Sargis; Ike |
Switch stand
|
|
US5395933A
(en)
|
1992-08-07 |
1995-03-07 |
Eastman Kodak Company |
Carbamazepine hapten analogues
|
|
CA2192467C
(en)
|
1994-06-10 |
2009-03-31 |
Alireza Rezaie |
Calcium binding recombinant antibody against protein c
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US5761894A
(en)
|
1996-09-25 |
1998-06-09 |
Magic Circle Corporation |
Grass striping attachment for lawn mowers
|
|
AU8148898A
(en)
|
1997-06-23 |
1999-01-04 |
Luminex Corporation |
Interlaced lasers for multiple fluorescence measurement
|
|
US6830731B1
(en)
|
1998-01-05 |
2004-12-14 |
Biosite, Inc. |
Immunoassay fluorometer
|
|
US6541669B1
(en)
|
1998-06-08 |
2003-04-01 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
|
US20030143233A1
(en)
|
1999-06-07 |
2003-07-31 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
|
US7163681B2
(en)
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
|
US6958156B2
(en)
|
2000-12-15 |
2005-10-25 |
Vyrex Corporation |
Isoflavone derivatives
|
|
US7193065B2
(en)
|
2001-07-13 |
2007-03-20 |
Roche Diagnostics Operations, Inc. |
Protease inhibitor conjugates and antibodies useful in immunoassay
|
|
US20040001828A1
(en)
*
|
2002-02-21 |
2004-01-01 |
Joseph Tuscano |
Treatment methods using anti-CD22 antibodies
|
|
EP2316468A1
(en)
|
2002-02-22 |
2011-05-04 |
Shire LLC |
Delivery system and methods for protecting and administering dextroamphetamine
|
|
AU2003217936A1
(en)
|
2002-03-28 |
2003-10-13 |
Eli Lilly And Company |
Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
|
|
SE0201738D0
(sv)
|
2002-06-07 |
2002-06-07 |
Aamic Ab |
Micro-fluid structures
|
|
AU2003259256A1
(en)
*
|
2002-07-29 |
2004-02-16 |
Potomac Pharma, LLC. |
Antipsychotic combination therapies and compositions of an alpha-2 adrenergic receptor antagonist and an atypical antipsychotic neuroleptic
|
|
AU2003264915A1
(en)
|
2002-08-05 |
2004-02-25 |
Eli Lilly And Company |
Piperazine substituted aryl benzodiazepines
|
|
CA2525251C
(en)
|
2003-05-09 |
2015-10-27 |
Duke University |
Cd20-specific antibodies and methods employing same
|
|
BRPI0413595B8
(pt)
|
2003-08-18 |
2021-05-25 |
H Lundbeck As |
sal de malonato, composição farmacêutica, uso de um sal de malonato, e, método de fabricação de um composto
|
|
ES2335589T3
(es)
|
2003-09-23 |
2010-03-30 |
Fermion Oy |
Preparacion de quetiapina.
|
|
CN101921279A
(zh)
|
2003-10-01 |
2010-12-22 |
阿得罗公司 |
螺环杂环衍生物及其应用方法
|
|
ATE411797T2
(de)
|
2003-10-23 |
2008-11-15 |
Otsuka Pharma Co Ltd |
Sterile injizierbare aripiprazol-formulierung mit kontrollierter freisetzung und verfahren
|
|
DE602004024236D1
(en)
|
2003-12-12 |
2009-12-31 |
Inverness Medical Switzerland |
Assay
|
|
SE0400662D0
(sv)
|
2004-03-24 |
2004-03-24 |
Aamic Ab |
Assay device and method
|
|
WO2005103250A1
(ja)
|
2004-04-26 |
2005-11-03 |
Takami Matsuyama |
葉酸リセプターベータ（FR-β）に対する単クローン抗体を含有する治療薬
|
|
SE527036C2
(sv)
|
2004-06-02 |
2005-12-13 |
Aamic Ab |
Analysanordning med reglerat flöde och motsvarande förfarande
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
FR2878850B1
(fr)
|
2004-12-02 |
2008-10-31 |
Cis Bio Internat Sa |
Derives de l'inositol-1-phosphate
|
|
US20060235005A1
(en)
|
2005-04-14 |
2006-10-19 |
Oak Labs, Corp. |
Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia
|
|
SE529254C2
(sv)
|
2005-06-17 |
2007-06-12 |
Aamic Ab |
Optiskt testsystem
|
|
SE528233C2
(sv)
|
2005-06-20 |
2006-09-26 |
Aamic Ab |
Metod och medel för att åstadkomma vätsketransport
|
|
SE529711C2
(sv)
|
2006-03-22 |
2007-11-06 |
Aamic Ab |
Fluorescensläsare
|
|
US8975374B2
(en)
|
2006-10-20 |
2015-03-10 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
|
|
JP2010507648A
(ja)
|
2006-10-25 |
2010-03-11 |
ラモット アット テル−アビブ ユニバーシティー リミテッド |
グルタミン酸ｎｍｄａ活性を有する新規向精神薬
|
|
US20080138842A1
(en)
|
2006-12-11 |
2008-06-12 |
Hans Boehringer |
Indirect lateral flow sandwich assay
|
|
WO2008082979A2
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Diagnostic test for the detection of a molecule or drug in whole blood
|
|
CN101091700B
(zh)
|
2007-07-03 |
2011-06-08 |
上海现代药物制剂工程研究中心有限公司 |
富马酸喹硫平缓控释制剂组合物及其制备用途
|
|
RU2010116351A
(ru)
|
2007-09-27 |
2012-05-20 |
Новартис АГ (CH) |
Мониторинг лекарственных средств
|
|
EP2320942B1
(en)
|
2008-07-21 |
2018-03-14 |
Probiodrug AG |
Diagnostic antibody assay
|
|
EP2331088A4
(en)
|
2008-08-06 |
2011-10-12 |
Gosforth Ct Holdings Pty Ltd |
COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC ILLNESSES
|
|
US20100069356A1
(en)
|
2008-09-17 |
2010-03-18 |
Auspex Pharmaceuticals, Inc. |
Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
|
|
CN102245605B
(zh)
|
2008-10-14 |
2016-01-27 |
阿斯利康(瑞典)有限公司 |
用于治疗细菌感染的稠合、螺环杂芳族化合物
|
|
EP2347015A4
(en)
|
2008-10-29 |
2012-12-19 |
Janssen Pharmaceutica Nv |
METHOD FOR THE TREATMENT OF PSYCHOSIS AND SCHIZOPHRENIA BASED ON POLYMORPHISMS IN THE ERBB4 GEN
|
|
EP2194048A1
(en)
|
2008-12-02 |
2010-06-09 |
Dirk Sartor |
Nitrate esters for the treatment of vascular and metabolic diseases
|
|
US8480333B2
(en)
|
2008-12-26 |
2013-07-09 |
Steven Edward DeMay |
Frame rail assemblies and interlocking frame rail systems
|
|
EP2389169A1
(en)
|
2009-01-26 |
2011-11-30 |
Egalet A/S |
Controlled release formulations with continuous efficacy
|
|
EP2406289B1
(en)
|
2009-03-10 |
2017-02-22 |
Baylor Research Institute |
Antigen presenting cell targeted anti-viral vaccines
|
|
CN107714703A
(zh)
|
2009-12-31 |
2018-02-23 |
凯姆制药公司 |
喹硫平的氨基酸缀合物、其制备和使用方法
|
|
EP3476218A1
(en)
|
2010-03-11 |
2019-05-01 |
Kempharm, Inc. |
Fatty acid conjugates of quetiapine, process for making and using the same
|
|
US8088594B2
(en)
*
|
2010-03-16 |
2012-01-03 |
Saladax Biomedical Inc. |
Risperidone immunoassay
|
|
WO2011159537A2
(en)
|
2010-06-15 |
2011-12-22 |
The Regents Of The University Of California |
Method and device for analyte detection
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
US9156822B2
(en)
|
2010-07-02 |
2015-10-13 |
The University Of North Carolina At Chapel Hill |
Functionally selective ligands of dopamine D2 receptors
|
|
US8623324B2
(en)
|
2010-07-21 |
2014-01-07 |
Aat Bioquest Inc. |
Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
|
|
NZ722096A
(en)
|
2011-12-15 |
2016-11-25 |
Alkermes Pharma Ireland Ltd |
Prodrugs of secondary amine compounds
|
|
SG11201501130PA
(en)
|
2012-08-16 |
2015-04-29 |
Janssen Pharmaceutica Nv |
Substituted pyrazoles as n-type calcium channel blockers
|
|
TR201816378T4
(tr)
|
2012-08-21 |
2018-11-21 |
Janssen Pharmaceutica Nv |
Olanzapin haptenleri.
|
|
ES2654413T3
(es)
|
2012-08-21 |
2018-02-13 |
Janssen Pharmaceutica, N.V. |
Anticuerpos a quetiapina y uso de los mismos
|
|
ES2788716T3
(es)
|
2012-08-21 |
2020-10-22 |
Janssen Pharmaceutica Nv |
Anticuerpos para haptenos de quetiapina y uso de los mismos
|
|
CA2882562C
(en)
|
2012-08-21 |
2019-08-27 |
Eric Hryhorenko |
Antibodies to aripiprazole and use thereof
|
|
ES2904838T3
(es)
|
2012-08-21 |
2022-04-06 |
Janssen Pharmaceutica Nv |
Haptenos de risperidona y paliperidona
|
|
JP6389177B2
(ja)
|
2012-08-21 |
2018-09-12 |
ヤンセン ファーマシューティカ エヌ．ベー． |
オランザピンハプテンに対する抗体及びその使用
|
|
CA2882490A1
(en)
|
2012-08-21 |
2014-02-27 |
Ortho-Clinical Diagnostics, Inc. |
Antibodies to paliperidone and use thereof
|
|
ES2652641T3
(es)
|
2012-08-21 |
2018-02-05 |
Janssen Pharmaceutica Nv |
Haptenos de aripiprazol y su uso en inmunoensayos
|
|
US9494608B2
(en)
|
2012-08-21 |
2016-11-15 |
Janssen Pharmaceutica Nv |
Antibodies to olanzapine and use thereof
|
|
ES2978909T3
(es)
|
2012-08-21 |
2024-09-23 |
Janssen Pharmaceutica Nv |
Anticuerpos contra haptenos de aripiprazol y uso de los mismos
|
|
AU2013305930B2
(en)
|
2012-08-21 |
2017-08-24 |
Saladax Biomedical Inc. |
Haptens of paliperidone
|
|
ES2822907T3
(es)
|
2012-08-21 |
2021-05-05 |
Janssen Pharmaceutica Nv |
Haptenos de quetiapina para su uso en inmunoensayos
|
|
JP2015529199A
(ja)
|
2012-08-21 |
2015-10-05 |
オルソ−クリニカル ダイアグノスティクス，インコーポレイティド |
パリペリドンハプテンに対する抗体及びその使用
|
|
CN104736565B
(zh)
|
2012-08-21 |
2019-03-12 |
詹森药业有限公司 |
利培酮半抗原的抗体及其用途
|
|
EP3462173B1
(en)
|
2012-08-21 |
2021-03-31 |
Janssen Pharmaceutica NV |
Antibodies to risperidone and use thereof
|
|
US9453002B2
(en)
|
2013-08-16 |
2016-09-27 |
Janssen Pharmaceutica Nv |
Substituted imidazoles as N-type calcium channel blockers
|
|
EP3390455A1
(en)
|
2015-12-17 |
2018-10-24 |
Janssen Pharmaceutica NV |
Antibodies to quetiapine and use thereof
|